Literature DB >> 16178054

The origin of tubular aggregates in human myopathies.

Frédéric Chevessier1, Stéphanie Bauché-Godard, Jean-Paul Leroy, Jeanine Koenig, Marion Paturneau-Jouas, Bruno Eymard, Daniel Hantaï, Martine Verdière-Sahuqué.   

Abstract

Tubular aggregates are morphological abnormalities characterized by the accumulation of densely packed tubules in skeletal muscle fibres. To improve knowledge of tubular aggregates, the formation and role of which are still unclear, the present study reports the electron microscopic analysis and protein characterization of tubular aggregates in six patients with 'tubular aggregate myopathy'. Three of the six patients also presented with myasthenic features. A large panel of immunochemical markers located in the sarcoplasmic reticulum, T-tubules, mitochondria, and nucleus was used. Despite differences in clinical phenotype, the composition of tubular aggregates, which contained proteins normally segregated differently along the sarcoplasmic reticulum architecture, was similar in all patients. All of these proteins, calsequestrin, RyR, triadin, SERCAs, and sarcalumenin, are involved in calcium uptake, storage, and release. The dihydropyridine receptor, DHPR, specifically located in the T-tubule, was also present in tubular aggregates in all patients. COX-2 and COX-7 mitochondrial proteins were not found in tubular aggregates, despite being observed close to them in the muscle fibre. The nuclear membrane protein emerin was found in only one case. Electron microscopy revealed vesicular budding from nuclei, and the presence of SAR-1 GTPase protein in tubular aggregates shown by immunochemistry, in all patients, suggests that tubular aggregates could arise from endoplasmic reticulum exit sites. Taken together, these results cast new light on the composition and significance of tubular aggregates. Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178054     DOI: 10.1002/path.1832

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  30 in total

1.  Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy.

Authors:  Stéphanie Bauché; Geoffroy Vellieux; Damien Sternberg; Marie-Joséphine Fontenille; Elodie De Bruyckere; Claire-Sophie Davoine; Guy Brochier; Julien Messéant; Lucie Wolf; Michel Fardeau; Emmanuelle Lacène; Norma Romero; Jeanine Koenig; Emmanuel Fournier; Daniel Hantaï; Nathalie Streichenberger; Veronique Manel; Arnaud Lacour; Aleksandra Nadaj-Pakleza; Sylvie Sukno; Françoise Bouhour; Pascal Laforêt; Bertrand Fontaine; Laure Strochlic; Bruno Eymard; Frédéric Chevessier; Tanya Stojkovic; Sophie Nicole
Journal:  J Neurol       Date:  2017-07-15       Impact factor: 4.849

2.  Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity.

Authors:  Alexis R Demonbreun; Ann E Rossi; Manuel G Alvarez; Kaitlin E Swanson; H Kieran Deveaux; Judy U Earley; Michele Hadhazy; Ravneet Vohra; Glenn A Walter; Peter Pytel; Elizabeth M McNally
Journal:  Am J Pathol       Date:  2013-10-29       Impact factor: 4.307

3.  Sequential stages in the age-dependent gradual formation and accumulation of tubular aggregates in fast twitch muscle fibers: SERCA and calsequestrin involvement.

Authors:  Simona Boncompagni; Feliciano Protasi; Clara Franzini-Armstrong
Journal:  Age (Dordr)       Date:  2011-02-12

4.  169th ENMC International Workshop Rare Structural Congenital Myopathies 6-8 November 2009, Naarden, The Netherlands.

Authors:  Hans H Goebel; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2011-03-29       Impact factor: 4.296

5.  The RNA-binding protein Rbfox1 regulates splicing required for skeletal muscle structure and function.

Authors:  Simona Pedrotti; Jimena Giudice; Adan Dagnino-Acosta; Mark Knoblauch; Ravi K Singh; Amy Hanna; Qianxing Mo; John Hicks; Susan Hamilton; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2015-01-09       Impact factor: 6.150

6.  SKELETAL MUSCLE MITOCHONDRIAL ALTERATIONS IN CARBOXYL TERMINUS OF HSC70 INTERACTING PROTEIN (CHIP) -/- MICE.

Authors:  Jonathan C Schisler; Cam Patterson; Monte S Willis
Journal:  Afr J Cell Pathol       Date:  2016-04

Review 7.  Diseases caused by mutations in ORAI1 and STIM1.

Authors:  Rodrigo S Lacruz; Stefan Feske
Journal:  Ann N Y Acad Sci       Date:  2015-10-15       Impact factor: 5.691

Review 8.  Role of STIM1/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease.

Authors:  Antonio Michelucci; Maricela García-Castañeda; Simona Boncompagni; Robert T Dirksen
Journal:  Cell Calcium       Date:  2018-10-30       Impact factor: 6.817

Review 9.  Update on muscle disease.

Authors:  J Witherick; S Brady
Journal:  J Neurol       Date:  2018-04-18       Impact factor: 4.849

10.  Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy.

Authors:  Johann Böhm; Frédéric Chevessier; André Maues De Paula; Catherine Koch; Shahram Attarian; Claire Feger; Daniel Hantaï; Pascal Laforêt; Karima Ghorab; Jean-Michel Vallat; Michel Fardeau; Dominique Figarella-Branger; Jean Pouget; Norma B Romero; Marc Koch; Claudine Ebel; Nicolas Levy; Martin Krahn; Bruno Eymard; Marc Bartoli; Jocelyn Laporte
Journal:  Am J Hum Genet       Date:  2013-01-17       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.